Suchergebnisse - (Person:"Lu, Xinjie")

PubPharm (24)

1

Long-Term Efficacy and Safety of Immunomodulatory Therapy for Atherosclerosis

enthalten in: Cardiovascular drugs and therapy | 2019

von Thota, L. | Ponnusamy, T. | Lu, X. | +1

2

Impact of Macrophages in Atherosclerosis

enthalten in: Current medicinal chemistry | 2016

von Lu, X.

3

Regulating Inflammatory Immune Response to Atherogenic Antigens Prevents Development and Progression of Atherosclerosis in New Zealand White Rabbits

enthalten in: The Canadian journal of cardiology | 2016

von Philip, S. | Ponnusamy, T. | Rao, L. | +6

4

Impact of MCP-1 in Atherosclerosis

enthalten in: Current pharmaceutical design | 2014

von Lin, J. | Kakkar, V. | Lu, X.

5

Oral dosing with multi-antigenic construct induces atheroprotective immune tolerance to individual peptides in mice

enthalten in: International journal of cardiology | 2014

von Mundkur, L. | Ponnusamy, T. | Philip, S. | +6

6

Impact of Matrix Metalloproteinases on Atherosclerosis

enthalten in: Current drug targets | 2014

von Lin, J. | Kakkar, V. | Lu, X.

7

The Roles of MicroRNAs in Atherosclerosis

enthalten in: Current medicinal chemistry | 2014

von Lu, X. | Kakkar, V.

8

Inflammasome and Atherogenesis

enthalten in: Current pharmaceutical design | 2014

von Lu, X. | Kakkar, V.

9

Activation of inflammatory cells and cytokines by peptide epitopes in vitro: a simple in-vitro screening assay for prioritizing them for in-vivo studies

enthalten in: Inflammation research | 2013

von Mundkur, L. | Varma, M. | Shivanandan, H. | +4

10

Impact of multiple antigenic epitopes from ApoB100, hHSP60 and Chlamydophila pneumoniae on atherosclerotic lesion development in Apob tm2Sgy Ldlr tm1Her J mice

enthalten in: Atherosclerosis | 2012

von Lu, X. | Xia, M. | Endresz, V. | +6